glp-1-based treatments approved for weight loss 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Comparing GLP‑1 Drugs With Other
Description
Ideal for those seeking current, actionable clinical strategies for metabolic health and private practice growth
With both GLP-1s and psychedelics becoming increasingly popular, it will be interesting to see what else is uncovered
Review Article Other versions: (Verbatim name) ID (Catalog Number) Invalid DOI was provided, please try again ContentsContents Article InfoArticle Info CiteCite MetricsMetrics CommentComment RelatedRelated FigsFigs TabsTabs RefsRefs CitedCited Article title Abstract Keywords Introduction Pharmacogenetics in type 2 diabetes What is glucagon-like peptide-1 (GLP-1) and their role in the glucose metabolism
Youll also continue to have regular follow-ups with a healthcare team to help you manage their dosage and any side effects they experience
